Federated Hermes Amends Arcturus Therapeutics Stake (SC 13G/A)
Ticker: ARCT · Form: SC 13G/A · Filed: Jan 17, 2024 · CIK: 1768224
| Field | Detail |
|---|---|
| Company | Arcturus Therapeutics Holdings Inc. (ARCT) |
| Form Type | SC 13G/A |
| Filed Date | Jan 17, 2024 |
| Risk Level | low |
| Pages | 9 |
| Reading Time | 11 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, pharmaceuticals
TL;DR
**Federated Hermes just updated their stake in Arcturus Therapeutics.**
AI Summary
Federated Hermes, Inc. has filed an amended Schedule 13G/A, indicating a change in their ownership stake in Arcturus Therapeutics Holdings Inc. as of December 31, 2023. This filing, an amendment number 2, shows that Federated Hermes continues to hold a significant, though potentially adjusted, position in the pharmaceutical company's common stock. For investors, this matters because large institutional holdings can influence stock stability and signal confidence (or lack thereof) in the company's future prospects.
Why It Matters
This filing updates Federated Hermes's ownership in Arcturus Therapeutics, providing transparency on institutional investor sentiment and potential influence on the stock.
Risk Assessment
Risk Level: low — This is a routine update from an institutional investor and does not inherently signal high risk for the company.
Analyst Insight
Investors should review the full SC 13G/A filing to understand the specific changes in Federated Hermes's ownership percentage and voting power in Arcturus Therapeutics, as this could signal a shift in institutional confidence.
Key Players & Entities
- Federated Hermes, Inc. (company) — the institutional investor filing the SC 13G/A
- Arcturus Therapeutics Holdings Inc. (company) — the subject company whose common stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- 03969T109 (other) — the CUSIP number for Arcturus Therapeutics Holdings Inc. common stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, specifically Amendment No. 2, as indicated in the filing title and form type.
Who is the subject company of this filing?
The subject company is Arcturus Therapeutics Holdings Inc., a pharmaceutical preparations company with CIK 0001768224, located at 10628 Science Center Drive, Suite 250, San Diego, CA 92121.
Who is the entity that filed this SC 13G/A?
The entity that filed this SC 13G/A is Federated Hermes, Inc., an investment advice company with CIK 0001056288, located at 1001 Liberty Avenue, Pittsburgh, PA 15222.
What is the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' is December 31, 2023, as stated on the cover page of the Schedule 13G.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the 'X' next to 'Rule 13d-1(b)' on the cover page.
Filing Stats: 2,813 words · 11 min read · ~9 pages · Grade level 9.2 · Accepted 2024-01-17 14:43:10
Filing Documents
- arct1567-form.htm (SC 13G/A) — 104KB
- image_001.jpg (GRAPHIC) — 114KB
- image_002.jpg (GRAPHIC) — 116KB
- 0001623632-24-000025.txt ( ) — 423KB
Ownership
Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. A. Federated Hermes, Inc. (a) Amount beneficially owned: 4,711,512 (b) Percent of class: 17.63% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 4,711,512 (ii)Shared power to vote or to direct the vote: 0 (iii)Sole power to dispose or to direct the disposition of: 4,711,512 (iv)Shared power to dispose or to direct the disposition of: 0 B. Voting Shares Irrevocable Trust (a) Amount beneficially owned: 4,711,512 (b) Percent of class: 17.63% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 4,711,512 (ii)Shared power to vote or to direct the vote: 0 (iii)Sole power to dispose or to direct the disposition of: 4,711,512 (iv)Shared power to dispose or to direct the disposition of: 0 C. Thomas R. Donahue (a) Amount beneficially owned: 4,711,512 (b) Percent of class: 17.63% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 0 (ii)Shared power to vote or to direct the vote: 4,711,512 (iii)Sole power to dispose or to direct the disposition of: 0 (iv)Shared power to dispose or to direct the disposition of: 4,711,512 D. Ann C. Donahue (a) Amount beneficially owned: 4,711,512 (b) Percent of class: 17.63% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 0 (ii)Shared power to vote or to direct the vote: 4,711,512 (iii)Sole power to dispose or to direct the disposition of: 0 (iv)Shared power to dispose or to direct the disposition of: 4,711,512 E. J. Christopher Donahue (a) Amount beneficially owned: 4,711,512 (b) Percent of class: 17.63% (c) Number of shares to which the person has: (i)Sole power to vote or to direct the vote: 0 (ii)Shared power to vote or to direct
Ownership of Five Percent or Less of a Class
Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: Instruction: Dissolution of a group requires a response to this item.
Ownership of More than Five Percent on Behalf of Another Person. NOT APPLICABLE
Item 6. Ownership of More than Five Percent on Behalf of Another Person. NOT APPLICABLE Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See Exhibit “1” Attached
Identification and Classification of Members of the Group: NOT APPLICABLE
Item 8. Identification and Classification of Members of the Group: NOT APPLICABLE
Notice of Dissolution of Group: NOT APPLICABLE
Item 9. Notice of Dissolution of Group: NOT APPLICABLE
Certification
Item 10. Certification (a) The following certification shall be included if the statement is filed pursuant to §240.13d-1(b); By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having the purpose or effect. (b) The following certification shall be included if the statement is filed pursuant to §204.13d-1(c): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 17, 2024 By: /s/J. Christopher Donahue Name/Title: J. Christopher Donahue, as President of Federated Hermes, Inc. Date: January 17, 2024 By: /s/Thomas R. Donahue Name/Title Thomas R. Donahue individually and as Trustee of Voting Shares Irrevocable Trust Date: January 17, 2024 By: /s/Ann C. Donahue Name/Title: Ann C. Donahue individually and as Trustee of Voting Shares Irrevocable Trust Date: January 17, 2024 By: /s/J. Christopher Donahue Name/Title J. Christopher Donahue individually and as Trustee of Voting Shares Irrevocable Trust The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a
CLASSIFICATION OF REPORTING PERSONS
ITEM 3 CLASSIFICATION OF REPORTING PERSONS Identity and Classification of Each Reporting Person IDENTITY CLASSIFICATION UNDER ITEM 3 Federated Hermes Equity Funds (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8) Federated Hermes Insurance Series (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8) Federated Equity Management Company of Pennsylvania (e) Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Federated Global Investment Management Corp. (e) Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Federated Hermes, Inc. (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) FII Holdings, Inc. (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) Voting Shares Irrevocable Trust (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) Thomas R. Donahue (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) Ann C. Donahue (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) J. Christopher Donahue (g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) Federated Hermes, Inc. (the “Parent”) is filing this schedule 13G because it is the parent holding company of Federated Equity Management Company of Pennsylvania and Federated Global Investment Management Corp. (the “Investment Advisers”), which act as investment advisers to registered investment companies and separate accounts that own shares of common stock in ARCTURUS THERAPEUTICS HOLDINGS, INC. (the “Reported Securities”). The Investment Advisers are wholly owned subsidiaries of FII Holdings, Inc., which is wholly owned subsidiary of Federated